News Sentiment

DNLI sentiment intelligence

Denali Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 58 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 25.68 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 50

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-0.6% over one week, +18.6% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Denali Therapeutics Price Target Announced at $29.00/Share by JP Morgan

Market Reaction

Balanced read

56/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction -0.6% Price digesting
Trend fit Trend active 18.6% over four weeks
Fair value 29.9% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 18
Neutral 34
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 50
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 13
TradingView 9
Stock Titan 8
Investing.com 5
simplywall.st 5
Moomoo 2
Sahm 2
Finviz 2

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 12
Analyst action 8
Regulatory and legal 4
Deals and strategy 3
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-58 of 58